Sam Jactel

Sam Jactel is the Founder and CEO of Ayble Health since June 2020, leading the organization in providing personalized gut health solutions through clinical protocols and advanced technology. In January 2024, Sam became an Invited Lecturer at Columbia University Mailman School of Public Health, contributing expertise on digital health. Additionally, Sam serves on the Board of Directors for Hypercell Technologies and as a Strategic Advisor for Pertinent Eco-Solutions. Previous roles include involvement in growth strategy at Ginkgo Bioworks, serving as a Flare Scholar at Flare Capital Partners, and working as a Business Strategy Consultant at Accenture. Sam's early career features positions in commercial strategy at Genzyme and research at Children's Healthcare of Atlanta. Sam holds an MBA from Northwestern University's Kellogg School of Management and degrees in Biology from Duke University and UNSW, alongside an IB Bilingual Diploma from Atlanta International School.